Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.
Saved in:
| Title: | Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. |
|---|---|
| Authors: | Collier DA; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK., Ferreira IATM; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Kotagiri P; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Datir RP; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK., Lim EY; Department of Medicine, University of Cambridge, Cambridge, UK., Touizer E; Division of Infection and Immunity, University College London, London, UK., Meng B; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Abdullahi A; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK., Elmer A; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Kingston N; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Graves B; NIHR Bioresource, Cambridge, UK., Le Gresley E; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Caputo D; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Bergamaschi L; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK., Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Bradley JR; Department of Medicine, University of Cambridge, Cambridge, UK.; NIHR Bioresource, Cambridge, UK., Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital, Cambridge, UK., Cortes-Acevedo P; Laboratorio de Inmunología, FES-Cuautitlán, UNAM, Mexico City, Mexico., Barcenas-Morales G; Laboratorio de Inmunología, FES-Cuautitlán, UNAM, Mexico City, Mexico., Linterman MA; Immunology Programme, Babraham Institute, Cambridge, UK., McCoy LE; Division of Infection and Immunity, University College London, London, UK., Davis C; MRC Centre for Virus Research, University of Glasgow, Glasgow, UK., Thomson E; MRC Centre for Virus Research, University of Glasgow, Glasgow, UK., Lyons PA; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., McKinney E; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. efm30@medschl.cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. efm30@medschl.cam.ac.uk., Doffinger R; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. rd270@medschl.cam.ac.uk., Wills M; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. mrw1004@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. mrw1004@cam.ac.uk., Gupta RK; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. rkg20@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk. |
| Corporate Authors: | CITIID-NIHR BioResource COVID-19 Collaboration |
| Source: | Nature [Nature] 2021 Aug; Vol. 596 (7872), pp. 417-422. Date of Electronic Publication: 2021 Jun 30. |
| Publication Type: | Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34192737 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Collier+DA%22">Collier DA</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Ferreira+IATM%22">Ferreira IATM</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Kotagiri+P%22">Kotagiri P</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Datir+RP%22">Datir RP</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Lim+EY%22">Lim EY</searchLink>; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Touizer+E%22">Touizer E</searchLink>; Division of Infection and Immunity, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Meng+B%22">Meng B</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Abdullahi+A%22">Abdullahi A</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Elmer+A%22">Elmer A</searchLink>; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Kingston+N%22">Kingston N</searchLink>; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Graves+B%22">Graves B</searchLink>; NIHR Bioresource, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Le+Gresley+E%22">Le Gresley E</searchLink>; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Caputo+D%22">Caputo D</searchLink>; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Bergamaschi+L%22">Bergamaschi L</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Smith+KGC%22">Smith KGC</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Bradley+JR%22">Bradley JR</searchLink>; Department of Medicine, University of Cambridge, Cambridge, UK.; NIHR Bioresource, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Ceron-Gutierrez+L%22">Ceron-Gutierrez L</searchLink>; Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Cortes-Acevedo+P%22">Cortes-Acevedo P</searchLink>; Laboratorio de Inmunología, FES-Cuautitlán, UNAM, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Barcenas-Morales+G%22">Barcenas-Morales G</searchLink>; Laboratorio de Inmunología, FES-Cuautitlán, UNAM, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Linterman+MA%22">Linterman MA</searchLink>; Immunology Programme, Babraham Institute, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22McCoy+LE%22">McCoy LE</searchLink>; Division of Infection and Immunity, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Davis+C%22">Davis C</searchLink>; MRC Centre for Virus Research, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Thomson+E%22">Thomson E</searchLink>; MRC Centre for Virus Research, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Lyons+PA%22">Lyons PA</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22McKinney+E%22">McKinney E</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. efm30@medschl.cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. efm30@medschl.cam.ac.uk.<br /><searchLink fieldCode="AU" term="%22Doffinger+R%22">Doffinger R</searchLink>; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. rd270@medschl.cam.ac.uk.<br /><searchLink fieldCode="AU" term="%22Wills+M%22">Wills M</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. mrw1004@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. mrw1004@cam.ac.uk.<br /><searchLink fieldCode="AU" term="%22Gupta+RK%22">Gupta RK</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. rkg20@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22CITIID-NIHR+BioResource+COVID-19+Collaboration%22">CITIID-NIHR BioResource COVID-19 Collaboration</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220410462%22">Nature</searchLink> [Nature] 2021 Aug; Vol. 596 (7872), pp. 417-422. <i>Date of Electronic Publication: </i>2021 Jun 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0410462 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-4687 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200280836%22">00280836 </searchLink><i>NLM ISO Abbreviation: </i>Nature <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34192737 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41586-021-03739-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 417 Titles: – TitleFull: Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Collier DA – PersonEntity: Name: NameFull: Ferreira IATM – PersonEntity: Name: NameFull: Kotagiri P – PersonEntity: Name: NameFull: Datir RP – PersonEntity: Name: NameFull: Lim EY – PersonEntity: Name: NameFull: Touizer E – PersonEntity: Name: NameFull: Meng B – PersonEntity: Name: NameFull: Abdullahi A – PersonEntity: Name: NameFull: Elmer A – PersonEntity: Name: NameFull: Kingston N – PersonEntity: Name: NameFull: Graves B – PersonEntity: Name: NameFull: Le Gresley E – PersonEntity: Name: NameFull: Caputo D – PersonEntity: Name: NameFull: Bergamaschi L – PersonEntity: Name: NameFull: Smith KGC – PersonEntity: Name: NameFull: Bradley JR – PersonEntity: Name: NameFull: Ceron-Gutierrez L – PersonEntity: Name: NameFull: Cortes-Acevedo P – PersonEntity: Name: NameFull: Barcenas-Morales G – PersonEntity: Name: NameFull: Linterman MA – PersonEntity: Name: NameFull: McCoy LE – PersonEntity: Name: NameFull: Davis C – PersonEntity: Name: NameFull: Thomson E – PersonEntity: Name: NameFull: Lyons PA – PersonEntity: Name: NameFull: McKinney E – PersonEntity: Name: NameFull: Doffinger R – PersonEntity: Name: NameFull: Wills M – PersonEntity: Name: NameFull: Gupta RK IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2021 Aug Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1476-4687 Numbering: – Type: volume Value: 596 – Type: issue Value: 7872 Titles: – TitleFull: Nature Type: main |
| ResultId | 1 |